GotoPER - Physicians' Education Resource
Back to Home

2023 IASLC North America Conference on Lung Cancer Satellite Symposia

December 2, 2023

Matching Treatment to Patient with EGFR-Mutant Lung Cancer: Mutation Subtypes, Co-Mutations, and Managing Resistance

Matching Treatment to Patient with EGFR-Mutant Lung Cancer: Mutation Subtypes, Co-Mutations, and Managing Resistance

Location: Chicago Marriott Magnificent Mile
Scientific Session: 12:00 - 1:00 PM CT

View Details

How CEACAM5 Expression Can Be Measured and Leveraged in NSCLC Care: Current Developments & Future Therapeutic Opportunities

How CEACAM5 Expression Can Be Measured and Leveraged in NSCLC Care: Current Developments & Future Therapeutic Opportunities

Location: Chicago Marriott Magnificent Mile
Scientific Session: 7:00 - 8:00 PM CT

View Details

Event Details

  • Event Date
    December 2, 2023
  • Location
    Chicago Marriott Magnificent Mile: Chicago Ballroom A/B/C/D
  • Target Audience
    This educational program is directed toward oncologists, pathologists, pulmonologists, and fellows interested in the treatment of NSCLC.

These presentations were approved by the IASLC as independent activities held in conjunction with the 2023 North America Conference on Lung Cancer. These presentations are not sponsored or endorsed by NACLC and are not part of the official IASLC accredited program.

Related Content

Live Tumor Board: From Trial to Practice–Integrating the Latest Evidence Into the Treatment of EGFR-Mutated NSCLCFree CE/CME

Live Tumor Board: From Trial to Practice–Integrating the Latest Evidence Into the Treatment of EGFR-Mutated NSCLC

Show Me the Data™: Post-TKI Sequencing in EGFR-Mutated NSCLC—Optimizing Current Strategies and Preparing for New Treatment ModalitiesFree CE/CME

Show Me the Data™: Post-TKI Sequencing in EGFR-Mutated NSCLC—Optimizing Current Strategies and Preparing for New Treatment Modalities

Medical Crossfire® — From Diagnostic Dilemmas to Potential Treatment Breakthroughs: Exploring Novel Targets for Extrapulmonary Neuroendocrine CarcinomasFree CE/CME

Medical Crossfire® — From Diagnostic Dilemmas to Potential Treatment Breakthroughs: Exploring Novel Targets for Extrapulmonary Neuroendocrine Carcinomas

Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung CancerFree CE/CME

Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Cancer